Human TFRC/CD71/IMD46 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_001128148.3)

Cat. No.: pGMAAV001214
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human TFRC/CD71/IMD46 Adeno-associated virus expression plasmid (ITR-vector) for TFRC AAV packaging, TFRC AAV production.The purified Human TFRC/CD71/IMD46 AAV particle serves as an invaluable asset for in-depth in vivo TFRC studies, mechanism of action (MOA) research, and the evolution of TFRC-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to TFRC/CD71 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV001214
Gene Name TFRC
Accession Number NM_001128148.3
Gene ID 7037
Species Human
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 2283 bp
Gene Alias CD71,IMD46,p90,T9,TFR,TFR1,TR,TRFR
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag Null
Promoter CMV
Resistance Amplicin

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-675 Pre-Made Lepunafusp biosimilar, Whole mAb, Anti-TfR1/TFRC Antibody: Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 therapeutic antibody
    Biosimilar GMP-Bios-INN-888 Pre-Made Lepunafusp Alfa Biosimilar, Fusion Protein targeting TFRC fused with human IDUA (iduronidase, alpha-L-) isoform 1 via a peptidyl linker: Recombinant therapeutic protein targeting CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90
    Biosimilar GMP-Bios-INN-943 Pre-Made Pabinafusp Alfa Biosimilar, Fusion Protein targeting TFRC fused with iduronate-2-sulfatase: Recombinant therapeutic protein targeting CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90
    Biosimilar GMP-Bios-ab-420 Pre-Made Pabinafusp biosimilar, Whole mAb Fusion, Anti-TFRC Antibody: Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 therapeutic antibody
    Target Antibody GM-Tg-g-T33976-Ab Anti-TFR1/ TFRC/ CD71 monoclonal antibody
    Target Antigen GM-Tg-g-T33976-Ag TFRC VLP (virus-like particle)
    ORF Viral Vector pGMLV000258 Human TFRC Lentivirus plasmid
    ORF Viral Vector pGMLV000504 Human TFRC Lentivirus plasmid
    ORF Viral Vector pGMLV001268 Human TFRC Lentivirus plasmid
    ORF Viral Vector pGMLV002278 Human TFRC Lentivirus plasmid
    ORF Viral Vector pGMAAV001214 Human TFRC Adeno-associate virus(AAV) plasmid
    ORF Viral Vector vGMLV000258 Human TFRC Lentivirus particle
    ORF Viral Vector vGMLV000504 Human TFRC Lentivirus particle
    ORF Viral Vector vGMLV001268 Human TFRC Lentivirus particle
    ORF Viral Vector vGMLV002278 Human TFRC Lentivirus particle
    ORF Viral Vector vGMAAV001214 Human TFRC Adeno-associate virus(AAV) particle


    Target information

    Target ID GM-T33976
    Target Name TFRC
    Gene ID 7037, 22042, 711568, 64678, 493880, 403703, 504698, 100034089
    Gene Symbol and Synonyms 2610028K12Rik,CD71,E430033M20Rik,IMD46,Mtvr1,p90,T9,TFR,TFR1,TFRC,TR,TRFR
    Uniprot Accession P02786
    Uniprot Entry Name TFR1_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, INN Index
    Disease Cancer
    Gene Ensembl ENSG00000072274
    Target Classification Tumor-associated antigen (TAA)

    This gene encodes a cell surface receptor necessary for cellular iron uptake by the process of receptor-mediated endocytosis. This receptor is required for erythropoiesis and neurologic development. Multiple alternatively spliced variants have been identified. [provided by RefSeq, Sep 2015]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.